Evidence map›Paper›PMID 41017132›Full record

ReviewMedical science monitor : international medical journal of experimental and clinical research2025

Age-Specific Pharmacology of Neuromuscular Blocking Agents: A Comprehensive Review.

Paweł Radkowski, Kacper Kowalczyk, Anna Łęczycka, Hubert Oniszczuk, Łukasz Grabarczyk

Abstract readReview
In one paragraph

Review in Medical science monitor : international medical journal of experimental and clinical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Error Traps in Pediatric Neuromuscular Block.Paediatric anaesthesia · 2026
    Review
  2. Muscle-Specific Differences in Neuromuscular Block and Quantitative Neuromuscular Monitoring: A Narrative Review.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Review
  3. Narrative Review of the Role of Nondepolarizing Neuromuscular Blocking Agents in Anesthesia: Perspective 2026.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Paweł RadkowskiDepartment of Anesthesiology and Intensive Care, Faculty of Medicine, Collegium Medicum University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.ORCID 0000-0002-9437-9458
Kacper KowalczykFaculty of Medicine, Collegium Medicum University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.ORCID 0009-0006-3138-351X
Anna ŁęczyckaFaculty of Medicine, Collegium Medicum University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.ORCID 0009-0004-9068-5222
Hubert OniszczukFaculty of Medicine, Medical University of Białystok, Białystok, Poland.ORCID 0009-0004-4503-1174
Łukasz GrabarczykAlarm Clock Clinic, Coma Recovery and Neurorehabilitation Center, Warsaw, Poland.ORCID 0000-0002-0022-2741

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuromuscular blocking agents (NMBAs) are essential in anesthesia, used primarily for intubation and synchronizing mechanical ventilation. They can be divided into depolarizing and non-depolarizing agents with an addition of reversal agents, which can be used to avoid residual muscle blockade. Their pharmacological properties vary among age groups due to physiological differences. In children, immature liver and kidney function, body composition, and immature neuromuscular junction influence drug properties. Elderly patients tend to have reduced organ function, more comorbidities, and greater vulnerability to stress. Ensuring anesthesia safety and preventing complications often requires adjusting doses and delivery regimens, which can be problematic, especially among inexperienced anesthesia personnel. To address this issue, we created this review to clarify dosage differences and their physiological bases. The article provides an overview of numerous clinical studies, including recent ones conducted on age-diverse patient populations, which, combined with an explanation of the pharmacological basis of NMBAs, is a valuable resource for anesthesiology with various levels of experience. The manuscript was based on 131 articles dating from 1987 to 2025, as well as the authors' knowledge and clinical experience.

Indexed as

Neuromuscular Blocking AgentsAgedAge FactorsAnesthesiaChildHumansNeuromuscular BlockadeNeuromuscular JunctionNeuromuscular Blocking Agents

Identifiers

PMID41017132
PMCPMC12492990

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.